Glucose-6-phosphate dehydrogenase (G6PD). Response of the human erythrocyte and another cells to the decrease in their activity

Colombia Medica

Volumn 38, Issue 1, 2007, Pages 68-75

  Bonilla, Javier Fernando ^a   Sánchez, Magna Carolina ^a   Chuaire, Lilian ^a  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

Congenital hemolytic anemia; Epidemiology; Erythrocyte; Genetics; Glucose 6 phosphate dehydrogenase deficiency; Physiology

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; PENTOSE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL GROWTH; CLINICAL FEATURE; COLOMBIA; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ELECTROPHORESIS; ERYTHROCYTE; ERYTHROPOIESIS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; INBORN ERROR OF METABOLISM; PHAGOCYTOSIS; PREECLAMPSIA; PREVALENCE; SIGNAL TRANSDUCTION; VASCULARIZATION; WORLD HEALTH ORGANIZATION; X CHROMOSOME;

EID: 34147143062     PISSN: 16579534     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Beutler E. Selectivity of proteases as a basis for tissue distribution of enzymes in hereditary deficiencies. Proc Natl Acad Sci USA 1983; 80: 3767-3768.
2. Grimes A. The hexose monophosphate pathway. In: Human red cell metabolism. Capítulo 8. Londes: Editorial Blackwell Scientific Publications; 1980. 192-201.
3. van Wijk R, van Solinge WW. The energy-less red blood cell is losterythrocyte enzyme abnormalities of glycolysis. Blood 2005; 10: 1604-1622.
4. Arese P, De Fiora A. Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency. Semin Hematol 1990; 27: 1-40.
5. IUPAC. The International Union of Pure and Applied Chemistry. Actualizada 30 de enero de 2007 (fecha de acceso 5 de febrero de 2007). URL disponible en: http://www.iupac.org/
6. Kirkman HN, Hendrickson EM. Glucose 6-phosphate dehydrogenase from human erythrocytes. II. Subactive states of the enzyme from normal persons. J Biol Chem 1962;237:2371-2376.
7. Chung A, Langdom R. Human erythrocyte glucose-6-phosphate dehydrogenase. I. Isolation and properties of the enzyme. J Biol Chem 1963; 238: 2309-2316.
8. Chung AE, Langdon RG. Human erythrocyteglucose-6-phosphate dehydrogenase II. Enzyme-coenzyme interrelationship. J Biol Chem 1963; 238: 2317-2324.
9. Marks PA, Tsutsui EA. Human glucose-6-P dehydrogenase: studies on the relation between antigenicity and catalytic activity. The role of TPN. Ann NY Acad Sci 1963; 103: 902-914.
10. Canepa L, Ferraris AM, Miglino M, Gaetani GF. Bound and unbound pyridine dinucleotides in normal and glucosa-6-phosphate dehydrogenase-deficient erythrocytes. Biochim Biophys Acta 1991; 1074: 101-104.
11. Bonsignore A, Cancedda R, Nicolini A, Damiani G, Deflora A. Metabolism of human erythrocyte glucose-6-phosphate dehydrogenase. VI. Interconversion of multiple molecular forms. Arch Biochem Biophys 1971; 147: 493-497.
12. + and NADPH. Biochim Biophys Acta 1967; 146: 18-25.
13. Iraimoud S, Sttamato T, Mauldin S, Biaglow J et al. Mutation in the glucose 6 phosphate deshydrogenase gene leads to inactivation of Ku DNA end binding during oxidative Stress. J Biol Chem 2002; 277: 9929-9935.
14. Longo L, Vanegas O, Patel L, Rosti V, Li H, Waka J. et al. Maternally transmitted severe glucose 6 phosphate dehydrogenase deficiency is an embryonic lethal. EMBO J 2002, 21: 4229-4239.
15. Prchal JT. G6PD activity is essential for definite erythropoiesis. Blood 2004; 104: 2997.
16. Wilmanski J, Villanueva E, Deitch EA, Spolarics Z. Glucose-6-phosphate dehydrogenase deficiency and the inflammatory response to endotoxin and polymicrobial sepsis. Crit Care Med 2007; 35: 510-518.
17. Leopold J, Walker J, Scribner, Voetsch B, Zhang Y, Losclazo A. et al. Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis. J Biol Chem 2003; 278: 32100-32106.
18. Chollet S, Gougerot M. Hereditary polymorphonuclear neutrophil deficiencies. Transfus Clin Biol 2000; 7: 533-539.
19. Beutler E. The hemolytic effect of primaquine and related compounds. A review. Blood 1959; 14: 103-139.
20. van Bruggen R, Bautista J, Petropoulou Th, de Boer M, van Zwieten R, Gómez-Gallego F, et al. Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic non-spherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 2002; 100: 1026-1033.
21. Tishkoff S, Varkonyi R, Cahinhinan L, Abbes S, Argyroupoulos G, Destro-Bisol G. et al. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin at alleles that confer malarial resistance. Science 2002; 293: 455-462.
22. Szeinberg A, Sheba C, Adam A. Enzymatic abnormality in erythrocytes of a population sensitive to Vicia faba or hemolytic anemia induced by drugs. Nature 1958; 181: 181-183.
23. WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull WHO 1989; 67: 601-611.
24. Beutler E. G6PDH deficiency. Blood 1994; 84: 3613-3636.
25. Luzzatto L. Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype. Hematology 2006; 91: 1303-1305.
26. Salvemini F, Franze A, Lervolino, Filosa S, Salzano S, Ursini M. Enhanced glutathione levels and oxidoresistance mediated by increased glucosa-6-phosphate dehydrogenase expression. J Biol Chem 1999; 274: 2750-2757.
27. Turrini F, Naitana A, Mannuzzu L, Pescarmona G, Arese P. Increased red cell calcium adenosine triphosphatase, and altered membrane proteins during Fava bean hemolysis in glucose-6-phosphate dehydrogenase-deficient (Mediterranean variants) individuals. Blood 1985; 66: 302-305.
28. Torres K, Tuero I, Colarossi A. Efecto de la hipoxia sobre la actividadde la enzima G6PD en eritrocitos. Facultad de Ciencias y Filosofia. Departamento de Bioquímica y Biología Molecular, Universidad Peruana Cayetano Heredia. Lima, Perú; 2001. Memorias del XII Jornada Científica Alberto Cazorla Talleri.
29. Carr M, Fandre MN, Oduwa FO. Glucose-6-phosphate dehydrogenase deficiency in two returning Operation Iraqi Freedom soldiers who developed hemolytic anemia while receiving primaquine prophylaxis for malaria. Mil Med 2005; 170: 273-276.
30. Gross R, Hurwitz R, Marks P. A hereditary enzymatic defect in erythrocyte metabolism: glucose-6-phosphate dehydrogenase deficiency. J Clinic Invest 1958; 37: 1176-1184.
31. Vulliamy T, Kaeda J, Ait C. Clinical and haematological consequences of recurrent G6PD mutations and a single new mutation causing chronic nonspherocytic haemolytic anaernia. Br J Haematol 1998; 101: 670-675.
32. Marks P, Banks J, Gross R. Genetic heterogeneity of glucose-6-phosphate dehydrogenase deficiency. Nature 1962; 194: 454-459.
33. Szeinberg A, Sheba C, Adam A. Selective occurrence of glutathione instability in red blood corpuscles of the various Jewish tribes. Blood 1958; 13: 1043-53.
34. Seller P, Best W, Nelson R, Becktel J. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med 1979; 300: 1001-1005.
35. Jaffé E. The reduction on methemoglobin in erythrocytes of a patient with congenital methemoglobinemia, subjects with erythrocytes glucose-6-phosphate dehydrogenase deficiency, and normal individuals. Blood 1963; 21: 561-572.
36. Oppenheim A, Jury C, Rund D, Vulliamy T, Luzzatto L. G6PD Mediterranean accounts for the high prevalence of G6PD deficiency in Kurdish Jews. Hum Gen 1993; 91: 293-296.
37. Beutler E. Glucose-6-phosphate dehydrogenase: New perspectives. Blood 1989; 73: 1397-1401.
38. Warsy A, Mohsen A. G6PD deficiency, distribution and variants in Saudi Arabia: an overview. Ann Saudi Med 2001; 21: 174-177.
39. Vaca G, Arámbula E, Monsalvo A, Medina C, Nuñez C, Sandoval L, et al. Glucose-6-phosphate dehydrogenase (G-6-PD) mutations in Mexico: four new G-6-PD variants. Blood Cells Mol Dis 2003; 31: 112-120.
40. Estrada M, Gutiérrez A, Palacios B, Pérez G, Rovira A, Vives J. Estudio bioquímico y molecular de la glucosa-6-fosfato deshidrogenasa en Cuba. Rev Cubana Hematol Inmunol Hemoterapia 1995; 2: 1-5.
41. Hirono A, Beutler E. Molecular cloning and nucleotide sequence of cDNA for human glucose-6-phosphate dehydrogenase variant A (-). Proc Natl Acad Sci USA 1988; 85: 3951-3954.
42. Persico M, Viglietto G, Martini G, Toniolo D, Paonessa G, Moscatelli C, et al. Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5′ non-coding region. Nucl Acid Res 1986; 14: 2511-2522.
43. Takizawa T, Huang IY, Ikuta T, Yoshida A. Human glucose-6-phosphate dehydrogenase: primary structure and cDNA cloning. Proc Natl Acad Sci USA 1986; 83: 4157-4161.
44. Martini G, Toniolo D, Vulliamy T, Luzzatto L, Dono R, Viglietto G, et al. Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase, EMBO J 1986; 5: 1849-1855.
45. + of human glucose-6-phosphate dehydrogenase by sequence analysis of mutants. Proc Nat Acad Sci USA 1989; 86: 10015-10017.
46. Mehta A, Mason P, Vulliamy T. Glucose-6-phosphate dehydrogenase deficiency. Clin Haematol 2000; 13: 21-38.
47. Bruggen R, Bautista J M, Petropoulou T, de Boer M, van Zwieten R, Gómez-Gallego F, et al. Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 2002; 100: 1026-1030.
48. Mehta A, Mason P, Vulliamy, T. Glucose-6-phosphate dehydrogenase deficiency. Clin Haematol 2000; 13: 21-38.
49. Dalal B, Kollmannsberger C. Drug-induced haemolysis and methaemoglobinaemia in glucose 6-phosphate dehydrogenase deficiency. Br J Haematol 2005, 129: 291-296.
50. Acosta T, Nuñez D, Suárez M. Anemia hemolítica por deficiencia de G6PD y estrés oxidativo. Rev Cubana Invest Biomed 2003; 22: 186-191.
51. Beutler E. Discrepancies between genotype and phenotype in hematology: an important frontier. Blood 2001; 98: 2597-2602.
52. Hundsdoerfer P, Vetter B, Kulozik A. Chronic haemolytic anaemia and glucose-6 phosphate dehydrogenase deficiency. Case report and review of the literature. Acta Haematol 2002; 108: 102-105.
53. Abdulhadi N. Glucose 6-phosphate dehydrogenase (G6PD) deficiency is a posible risk factor for the development of preeclampsia. Med Hypotheses 2004; 62: 780-782.
54. Saunders M, Slatkin M, Garner C, Hammer M, Nachman M. The extent of linkage desequilibrium caused by selection on G6PD in humans. Genetics 2005; 171: 1219-1229.
55. Gurbuz N, Aksu T, Van Noorden C. Biochemical and cytochemical evaluation of heterozygote individuals with glucose-6-phosphate dehydrogenase deficiency. Acta Histochem 2005; 107: 261-267.
56. Tagarelli A, Piro A, Bastone L, Condino F, Tagarelli G. Reliability of quantitative and qualitative tests to identify heterozygotes carryng severe or mild G6PD deficiency. Clin Biochem 2006; 39: 183-186.